Optic nerve glioma historical perspective: Difference between revisions
YazanDaaboul (talk | contribs) No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Optic nerve glioma was first described in 1816 by Scarpa. | |||
==Historical Perspective== | ==Historical Perspective== | ||
Optic pathway gliomas are glial tumors that can affect the optic nerves, chiasm, tracts, and radiations, as well as adjacent neurologic structures. Since Scarpa first described an optic nerve glioma in 1816,1 many case reports and reviews have followed in order to characterize these lesions further. There is considerable controversy in the literature over the biologic behavior and optimum therapy for these tumors. Recent large literature reviews have proved to be valuable resources when considering management of patients with optic glioma. The reader is directed to excellent reviews conducted by Alvord and Lofton2 in 1988, and most recently by Dutton3 in 1994. After discussing the clinical features and diagnostic appearance of optic pathway gliomas, this chapter will provide an overview of various treatment regimens. Attention will then be directed to a different entity, the rare malignant optic glioma of adulthood, which is both aggressive and lethal. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 18:33, 9 October 2015
|
Optic nerve glioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Optic nerve glioma historical perspective On the Web |
|
American Roentgen Ray Society Images of Optic nerve glioma historical perspective |
|
Risk calculators and risk factors for Optic nerve glioma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Optic nerve glioma was first described in 1816 by Scarpa.
Historical Perspective
Optic pathway gliomas are glial tumors that can affect the optic nerves, chiasm, tracts, and radiations, as well as adjacent neurologic structures. Since Scarpa first described an optic nerve glioma in 1816,1 many case reports and reviews have followed in order to characterize these lesions further. There is considerable controversy in the literature over the biologic behavior and optimum therapy for these tumors. Recent large literature reviews have proved to be valuable resources when considering management of patients with optic glioma. The reader is directed to excellent reviews conducted by Alvord and Lofton2 in 1988, and most recently by Dutton3 in 1994. After discussing the clinical features and diagnostic appearance of optic pathway gliomas, this chapter will provide an overview of various treatment regimens. Attention will then be directed to a different entity, the rare malignant optic glioma of adulthood, which is both aggressive and lethal.